203 related articles for article (PubMed ID: 7842512)
1. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture.
Riad M; Emerit MB; Hamon M
Brain Res Dev Brain Res; 1994 Oct; 82(1-2):245-58. PubMed ID: 7842512
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
[TBL] [Abstract][Full Text] [Related]
3. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
4. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
Jolas T; Haj-Dahmane S; Lanfumey L; Fattaccini CM; Kidd EJ; Adrien J; Gozlan H; Guardiola-Lemaitre B; Hamon M
Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):453-63. PubMed ID: 7686633
[TBL] [Abstract][Full Text] [Related]
5. Modulation of acetylcholine and 5-hydroxytryptamine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts containing cholinergic and/or serotonergic neurons.
Suhr R; Balse E; Haaf A; Kelche C; Cassel JC; Jackisch R
Brain Res Bull; 1999 Sep; 50(1):15-25. PubMed ID: 10507467
[TBL] [Abstract][Full Text] [Related]
6. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Borsini F; Ceci A; Bietti G; Donetti A
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of 5-HT1A receptor inhibits apoptosis induced by serum deprivation in cultured neurons from chick embryo.
Ahlemeyer B; Krieglstein J
Brain Res; 1997 Nov; 777(1-2):179-86. PubMed ID: 9449427
[TBL] [Abstract][Full Text] [Related]
8. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):303-11. PubMed ID: 9303566
[TBL] [Abstract][Full Text] [Related]
11. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
12. Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.
Schreiber R; Opitz K; Glaser T; De Vry J
Psychopharmacology (Berl); 1993; 112(1):100-10. PubMed ID: 7870997
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.
Cox RF; Meller E; Waszczak BL
Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
15. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
16. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
Ryan CN; Evenden JL; Petterson M
Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
[TBL] [Abstract][Full Text] [Related]
17. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
[TBL] [Abstract][Full Text] [Related]
18. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
19. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.
Fanelli RJ; McMonagle-Strucko K
Synapse; 1992 Sep; 12(1):75-81. PubMed ID: 1357765
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
